Hepcinat Plus

Purpose and properties of the drug

Hepatitis " C " is currently a dangerous liver disease that occurs without symptoms and can quickly turn into a chronic phase. In order to cure hepatitis " C " requires significant funds and time. If the patient is not properly treated, there is a chance that this disease will develop into cirrhosis or even liver cancer.

Virologists have invented an effective and effective remedy for the treatment of hepatitis "C". This is a direct-acting drug Hepcinat Plus (Hepcinate Plus).
It includes a complex of two drugs: Sofosbuvir and Daclatasvir.

Hepcinat Plus. Photo: gepa-net.com

SOFOSBUVIR-blocks viruses, phage stops reproduction.

DACLATASVIR-it does not allow the spread of infection through the human circulatory system.

This drug suppresses hepatitis C viruses of genotypes 1-5.
The price of the Indian medicine Hepcinate Plus is rather high, but it is much lower than the American original and is available for most residents of Russia.

Detailed description of Hepcinate Plus, you will find follow the link:

Advantages of the tool

Hepcinat Plus acts on the phage's enzymatic system.

Hepcinat Plus

The advantages of this drug are as follows:

  • it does not have toxic properties on the liver;
  • the side effect of therapy with these drugs is minimal;
  • safety of the specified vehicle at altitude;
  • the combination of its two antiviral components acts directly on the virus, without affecting other cells in the human body;
  • the probability of recovery of the patient reaches 98%-100%;
  • assimilation of the drug is very fast, which allows the ingredients to immediately fight the virus;
  • it is convenient to take the drug, due to the special form of the tablet.

Using Hepcinat Plus for the treatment of hepatitis C virus, you will soon be cured of this dangerous disease.

Pharmacy "Gepa-net" will give you the opportunity to purchase this product.

Just contact our manager and he will advise you, place an order and arrange shipment to any region of Russia.

Leave a Reply

Your email address will not be published.

en_GBEnglish (UK)